LEXINGTON, Mass.--(BUSINESS WIRE)--Critical Therapeutics, Inc. (Nasdaq: CRTX), a biopharmaceutical company focused on developing and commercializing innovative products for respiratory, inflammatory and critical care diseases, today announced that Tucker Kelly, 36, has been appointed to the position of the chief financial officer and senior vice president of finance and corporate development, effective August 20, 2007.
